Low DEDD expression in breast cancer cells indicates higher sensitivity to the Bcl-2-specific inhibitor ABT-199.
Biochem Biophys Res Commun
; 525(3): 549-556, 2020 05 07.
Article
in En
| MEDLINE
| ID: mdl-32113682
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sulfonamides
/
Breast Neoplasms
/
Bridged Bicyclo Compounds, Heterocyclic
/
Proto-Oncogene Proteins c-bcl-2
/
DNA-Binding Proteins
/
Death Domain Receptor Signaling Adaptor Proteins
Type of study:
Diagnostic_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Biochem Biophys Res Commun
Year:
2020
Type:
Article
Affiliation country:
China